Loading clinical trials...
Loading clinical trials...
Blood Flow Restriction Training for the Quad: Comparing Daily Training vs. Training Twice a Week
This study will randomize healthy adults who regularly perform resistance training exercises for the lower extremities (2x a week) to one of three groups: a blood flow restriction (BFR) exercise group that trains 2x a week, a BFR exercise group that trains 5x a week, and a control group that does not perform any additional BFR exercise. Those randomized to the BFR groups will perform the unilateral 90-0 knee extension exercise followed by the bilateral squat. Subjects will have the BFR applied to their dominant lower extremity and will perform 4 sets (30/15/15/15 reps) per exercise. Training will initial start at 30% of 1RM with training intensity increased by 5% every 2 weeks. The training program will last 8 weeks. Pre- and posttests include ultrasound imaging of the dominant leg rectus femoris and strength testing via hand held dynamometry.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
George Fox University School of Physical Therapy
Newberg, Oregon, United States
George Fox University
Newberg, Oregon, United States
Start Date
September 1, 2020
Primary Completion Date
June 30, 2022
Completion Date
June 30, 2022
Last Updated
April 25, 2022
55
ESTIMATED participants
5x a week BFR training group
OTHER
2x a week BFR training group
OTHER
Lead Sponsor
George Fox University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06976281